Cited by 3,510SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral Infections and Outbreaks Research

SARS and MERS: recent insights into emerging coronaviruses

Open access
de Wit, Emmie, van Doremalen, Neeltje, Falzarano, Darryl, Munster, Vincent J.·2016·Nature Reviews Microbiology

Abstract

The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 marked the second introduction of a highly pathogenic coronavirus into the human population in the twenty-first century. The continuing introductions of MERS-CoV from dromedary camels, the subsequent travel-related viral spread, the unprecedented nosocomial outbreaks and the high case-fatality rates highlight the need for prophylactic and therapeutic measures. Scientific advancements since the 2002-2003 severe acute respiratory syndrome coronavirus (SARS-CoV) pandemic allowed for rapid progress in our understanding of the epidemiology and pathogenesis of MERS-CoV and the development of therapeutics. In this Review, we detail our present understanding of the transmission and pathogenesis of SARS-CoV and MERS-CoV, and discuss the current state of development of measures to combat emerging coronaviruses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrmicro.2016.81

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SARS-CoV-1 and MERS-CoV activate NF-κB in a manner dependent on MyD88 through PRRs, such as RIG-I and MDA5, leading to the activation of pro-inflammatory cytokines including IL-6, TNFα, IL-8 and CCL2.

    “SARS-CoV-1 and MERS-CoV activate NF-κB in a manner dependent on MyD88 through PRRs, such as retinoic acid-inducible gene I protein (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), leading to the activation of a variety of pro-inflammatory cytokines, including IL-6, TNFα, IL-8 and CC-chemokine ligand 2 (CCL2) (335).”

    From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [335]

    The “Immune evasion” passage in The pathogenesis of SARS-CoV and MERS-CoV (page unavailable) describes RIG-I/MDA5 detection, signalling involving MYD88, NF-κB activation, and transcription of pro-inflammatory cytokines. The “Immunopathology” passage names IL-6, IL-8 and CCL2 as elevated in SARS patients, but does not link those specific molecules to this pathway. Our copy does not establish that the pathway is MYD88-dependent or identify TNFα as one of its products. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • ARDS in COVID-19 is considered the result of cytokine storm, resembling the disease caused by SARS-CoV-1 and Middle East respiratory syndrome coronavirus.

    “ARDS in COVID-19 is considered the result of cytokine storm (12–17), resembling the disease caused by SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV) (335).”

    From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [335]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 158 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [127]Houser KV Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection J. Infect. Dis. 2016 213 1557 1561 26941283 PMC4837915

Cited by

Sorted by citations

Authors
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J.
Affiliations
  • University of Saskatchewan (CA)
  • National Institutes of Health (US)
Corresponding author
Munster, Vincent J.
Venue
Nature Reviews Microbiology
Published
2016-06-27
Volume
14
Issue
8
Pages
523-534
ISSN
  • 1740-1526 (ISSN-L)
  • 1740-1534
OpenAlex
W2470646526
Cited by
3,510
References
158
Citations by year
2026: 63 · 2025: 107 · 2024: 173 · 2023: 276 · 2022: 421 · 2021: 893 · 2020: 1432 · 2019: 52 · 2018: 37 · 2017: 46 · 2016: 8
FWCI
7.32
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Microbiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
Keywords
SARS-CoV, MERS-CoV, emerging coronaviruses, virus transmission, pathogenesis, Camelus dromedarius, hospital outbreak, case fatality, prophylaxis, antiviral agents
MeSH terms
Animals, Camelus, Cross Infection, Disease Outbreaks, Humans, Travel, Virus Replication, Coronavirus Infections, Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Immune Evasion, Pandemics, Middle East Respiratory Syndrome Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review